Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2022, Issue -, Pages 1-18
Publisher
Hindawi Limited
Online
2022-02-10
DOI
10.1155/2022/9719671
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The migration behavior of human glioblastoma cells is influenced by the redox-sensitive human macrophage capping protein CAPG
- (2021) Nina Prescher et al. FREE RADICAL BIOLOGY AND MEDICINE
- RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors
- (2021) Parasvi S. Patel et al. JOURNAL OF CLINICAL INVESTIGATION
- Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase
- (2021) Cristina Valero et al. JAMA Oncology
- Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
- (2021) Milena Hornburg et al. CANCER CELL
- GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA
- (2021) Chenwei Li et al. NUCLEIC ACIDS RESEARCH
- Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling
- (2021) Zhaodong Ji et al. Frontiers in Cell and Developmental Biology
- Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment
- (2021) Haizhou Ji et al. DISEASE MARKERS
- Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond
- (2021) Francesca De Felice et al. Journal of Oncology
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer
- (2020) Tina Bagratuni et al. EUROPEAN JOURNAL OF CANCER
- ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
- (2020) Ya‐Ru Miao et al. Advanced Science
- Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
- (2020) Alejandro Jiménez-Sánchez et al. NATURE GENETICS
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Integrated analysis identified CAPG as a prognosis factor correlated with immune infiltrates in lower‐grade glioma
- (2020) Jinrui Wei et al. Clinical and Translational Medicine
- Comparative Toxicogenomics Database (CTD): update 2021
- (2020) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
- (2020) Chang Yang et al. Frontiers in Immunology
- High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma
- (2020) Cheng-Yu Jin et al. Aging-US
- Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
- (2019) Noor A. Lokman et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Advancing Drug Development in Gynecologic Malignancies
- (2019) Julia A Beaver et al. CLINICAL CANCER RESEARCH
- TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer
- (2019) Jitka Fucikova et al. CLINICAL CANCER RESEARCH
- Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells
- (2019) Q. Sheng et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription
- (2018) Sheng Huang et al. Theranostics
- Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA
- (2018) Qi Yang et al. Biomed Research International
- Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
- (2018) Jieru Zhou et al. Cancer Immunology Research
- Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy
- (2018) Yun Zhou et al. OncoImmunology
- The DifferentialNet database of differential protein–protein interactions in human tissues
- (2017) Omer Basha et al. NUCLEIC ACIDS RESEARCH
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility – A proteomics study
- (2015) David M Gau et al. CELL CYCLE
- RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse
- (2015) Zhi-Ping Liu et al. Database-The Journal of Biological Databases and Curation
- Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
- (2015) Francesca De Felice et al. Journal of Immunology Research
- Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer
- (2014) Panagiotis A. Konstantinopoulos et al. GYNECOLOGIC ONCOLOGY
- NetworkAnalyst - integrative approaches for protein–protein interaction network analysis and visual exploration
- (2014) Jianguo Xia et al. NUCLEIC ACIDS RESEARCH
- Macrophage Capping Protein CapG Is a Putative Oncogene Involved in Migration and Invasiveness in Ovarian Carcinoma
- (2014) J. Glaser et al. Biomed Research International
- New perspectives of valproic acid in clinical practice
- (2013) Lenka Činčárová et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
- (2013) Tracy X. Cui et al. IMMUNITY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma
- (2012) Kazuya Kimura et al. Journal of Proteomics
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
- (2010) David Warde-Farley et al. NUCLEIC ACIDS RESEARCH
- Pronounced Phenotype in Activated Regulatory T Cells during a Chronic Helminth Infection
- (2009) L. E. Layland et al. JOURNAL OF IMMUNOLOGY
- Valproic acid resensitizes cisplatin-resistant ovarian cancer cells
- (2008) Ching-Tai Lin et al. CANCER SCIENCE
- Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells
- (2008) Rosa Puca et al. GYNECOLOGIC ONCOLOGY
- The impact of T-cell immunity on ovarian cancer outcomes
- (2008) Brad H. Nelson IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation